<VariationArchive VariationID="553278" VariationName="NM_000091.5(COL4A3):c.2535del (p.Leu846fs)" VariationType="Deletion" Accession="VCV000553278" Version="7" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2018-08-05" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="541922" VariationID="553278">
      <GeneList>
        <Gene Symbol="COL4A3" FullName="collagen type IV alpha 3 chain" GeneID="1285" HGNC_ID="HGNC:2204" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q36.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="227164624" stop="227314792" display_start="227164624" display_stop="227314792" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="228029280" stop="228179507" display_start="228029280" display_stop="228179507" Strand="+" />
          </Location>
          <OMIM>120070</OMIM>
        </Gene>
        <Gene Symbol="MFF-DT" FullName="MFF divergent transcript" GeneID="654841" HGNC_ID="HGNC:41067" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q36.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="227221052" stop="227325164" display_start="227221052" display_stop="227325164" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000091.5(COL4A3):c.2535del (p.Leu846fs)</Name>
      <CanonicalSPDI>NC_000002.12:227282410:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q36.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="227282411" stop="227282411" display_start="227282411" display_stop="227282411" variantLength="1" positionVCF="227282410" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="228147127" stop="228147127" display_start="228147127" display_stop="228147127" variantLength="1" positionVCF="228147126" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>L846fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.228147127del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.228147127del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.227282411del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.227282411del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011591.1" sequenceAccession="NG_011591" sequenceVersion="1" change="g.122847del">
            <Expression>NG_011591.1:g.122847del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000091.5" sequenceAccession="NM_000091" sequenceVersion="5" change="c.2535del" MANESelect="true">
            <Expression>NM_000091.5:c.2535del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000082.2" sequenceAccession="NP_000082" sequenceVersion="2" change="p.Leu846fs">
            <Expression>NP_000082.2:p.Leu846fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_230" sequenceAccession="LRG_230">
            <Expression>LRG_230:g.122847del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000091.4" sequenceAccession="NM_000091" sequenceVersion="4" change="c.2535delC">
            <Expression>NM_000091.4:c.2535delC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="993103826" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00002" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00009" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000091.5(COL4A3):c.2535del (p.Leu846fs) AND Autosomal recessive Alport syndrome" Accession="RCV000668688" Version="2">
        <ClassifiedConditionList TraitSetID="5721">
          <ClassifiedCondition DB="MedGen" ID="C4746745">Autosomal recessive Alport syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-08-11" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000091.5(COL4A3):c.2535del (p.Leu846fs) AND not provided" Accession="RCV001384962" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-12-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000091.5(COL4A3):c.2535del (p.Leu846fs) AND multiple conditions" Accession="RCV002493101" Version="2">
        <ClassifiedConditionList TraitSetID="13181">
          <ClassifiedCondition DB="MedGen" ID="C5882663">Autosomal dominant Alport syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4746745">Autosomal recessive Alport syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0241908">Benign familial hematuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-24" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-01-24" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2018-08-05" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24854265</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8956999</ID>
        </Citation>
        <DescriptionHistory Dated="2021-05-10">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="13181" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="158" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Alport syndrome dominant type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Renal failure and sensorineural hearing loss</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant Alport syndrome</ElementValue>
                <XRef ID="MONDO:0007086" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alport syndrome 3, autosomal dominant</ElementValue>
                <XRef ID="Alport+Syndrome+Dominant+Type/336" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALPORT SYNDROME 3A, AUTOSOMAL DOMINANT</ElementValue>
                <XRef Type="MIM" ID="104200" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ATS3A</ElementValue>
                <XRef Type="MIM" ID="104200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">In Alport syndrome (AS) a spectrum of phenotypes ranging from progressive renal disease with extrarenal abnormalities to isolated hematuria with a non-progressive or very slowly progressive course is observed. Approximately two thirds of AS is X-linked (XLAS); approximately 15% is autosomal recessive (ARAS), and approximately 20% is autosomal dominant (ADAS). In the absence of treatment, renal disease progresses from microscopic hematuria (microhematuria) to proteinuria, progressive renal insufficiency, and end-stage renal disease (ESRD) in all males with XLAS, and in all males and females with ARAS. Progressive sensorineural hearing loss (SNHL) is usually present by late childhood or early adolescence. Ocular findings include anterior lenticonus (which is virtually pathognomonic), maculopathy (whitish or yellowish flecks or granulations in the perimacular region), corneal endothelial vesicles (posterior polymorphous dystrophy), and recurrent corneal erosion. In individuals with ADAS, ESRD is frequently delayed until later adulthood, SNHL is relatively late in onset, and ocular involvement is rare.</Attribute>
                <XRef ID="NBK1207" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="624" />
                <XRef ID="624" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301386</ID>
                <ID Source="BookShelf">NBK1207</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">22166944</ID>
              </Citation>
              <XRef ID="63" DB="Orphanet" />
              <XRef ID="88918" DB="Orphanet" />
              <XRef ID="C5882663" DB="MedGen" />
              <XRef ID="MONDO:0007086" DB="MONDO" />
              <XRef Type="MIM" ID="104200" DB="OMIM" />
            </Trait>
            <Trait ID="282" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Alport syndrome recessive type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nephropathy and deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">COL4A4 Alport Syndrome and Thin Basement Membrane Nephropathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="203780" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive Alport syndrome</ElementValue>
                <XRef ID="MONDO:0008762" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ATS2</ElementValue>
                <XRef Type="MIM" ID="203780" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">COL4A3-Related Nephropathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">COL4A4-Related Nephropathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">In Alport syndrome (AS) a spectrum of phenotypes ranging from progressive renal disease with extrarenal abnormalities to isolated hematuria with a non-progressive or very slowly progressive course is observed. Approximately two thirds of AS is X-linked (XLAS); approximately 15% is autosomal recessive (ARAS), and approximately 20% is autosomal dominant (ADAS). In the absence of treatment, renal disease progresses from microscopic hematuria (microhematuria) to proteinuria, progressive renal insufficiency, and end-stage renal disease (ESRD) in all males with XLAS, and in all males and females with ARAS. Progressive sensorineural hearing loss (SNHL) is usually present by late childhood or early adolescence. Ocular findings include anterior lenticonus (which is virtually pathognomonic), maculopathy (whitish or yellowish flecks or granulations in the perimacular region), corneal endothelial vesicles (posterior polymorphous dystrophy), and recurrent corneal erosion. In individuals with ADAS, ESRD is frequently delayed until later adulthood, SNHL is relatively late in onset, and ocular involvement is rare.</Attribute>
                <XRef ID="NBK1207" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="625" />
                <XRef ID="625" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301386</ID>
                <ID Source="BookShelf">NBK1207</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">22166944</ID>
              </Citation>
              <XRef ID="63" DB="Orphanet" />
              <XRef ID="88919" DB="Orphanet" />
              <XRef ID="C4746745" DB="MedGen" />
              <XRef ID="MONDO:0008762" DB="MONDO" />
              <XRef Type="MIM" ID="203780" DB="OMIM" />
            </Trait>
            <Trait ID="2022" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Benign familial hematuria</ElementValue>
                <XRef ID="Benign+Familial+Hematuria/794" DB="Genetic Alliance" />
                <XRef ID="236421001" DB="SNOMED CT" />
              </Name>
              <XRef ID="C0241908" DB="MedGen" />
              <XRef ID="MONDO:0957317" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS141200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5721" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="282" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Alport syndrome recessive type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nephropathy and deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">COL4A4 Alport Syndrome and Thin Basement Membrane Nephropathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="203780" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120070.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120131.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive Alport syndrome</ElementValue>
                <XRef ID="MONDO:0008762" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ATS2</ElementValue>
                <XRef Type="MIM" ID="203780" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">COL4A3-Related Nephropathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">COL4A4-Related Nephropathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">In Alport syndrome (AS) a spectrum of phenotypes ranging from progressive renal disease with extrarenal abnormalities to isolated hematuria with a non-progressive or very slowly progressive course is observed. Approximately two thirds of AS is X-linked (XLAS); approximately 15% is autosomal recessive (ARAS), and approximately 20% is autosomal dominant (ADAS). In the absence of treatment, renal disease progresses from microscopic hematuria (microhematuria) to proteinuria, progressive renal insufficiency, and end-stage renal disease (ESRD) in all males with XLAS, and in all males and females with ARAS. Progressive sensorineural hearing loss (SNHL) is usually present by late childhood or early adolescence. Ocular findings include anterior lenticonus (which is virtually pathognomonic), maculopathy (whitish or yellowish flecks or granulations in the perimacular region), corneal endothelial vesicles (posterior polymorphous dystrophy), and recurrent corneal erosion. In individuals with ADAS, ESRD is frequently delayed until later adulthood, SNHL is relatively late in onset, and ocular involvement is rare.</Attribute>
                <XRef ID="NBK1207" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="625" />
                <XRef ID="625" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301386</ID>
                <ID Source="BookShelf">NBK1207</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">22166944</ID>
              </Citation>
              <XRef ID="63" DB="Orphanet" />
              <XRef ID="88919" DB="Orphanet" />
              <XRef ID="C4746745" DB="MedGen" />
              <XRef ID="MONDO:0008762" DB="MONDO" />
              <XRef Type="MIM" ID="203780" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1543633" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="727208|OMIM:203780" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000793330" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-08-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="G" referenceAllele="GC" start="228147126" stop="228147127" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000091.4:c.2535delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="203780" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5432981" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000091.5:c.2535del|OMIM:104200;141200;203780" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002781072" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000091.5:c.2535del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="104200" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="141200" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="203780" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3110315" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="6225770|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001584669" DateUpdated="2024-02-20" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-12-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8956999</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24854265</ID>
          </Citation>
          <Comment>This variant has not been reported in the literature in individuals with COL4A3-related conditions. ClinVar contains an entry for this variant (Variation ID: 553278). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu846Trpfs*37) in the COL4A3 gene. It is expected to result in an absent or disrupted protein product. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in COL4A3 are known to be pathogenic (PMID: 8956999, 24854265).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.228147127del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3110315" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1543633" TraitType="Disease" MappingType="XRef" MappingValue="203780" MappingRef="OMIM">
        <MedGen CUI="C4746745" Name="Autosomal recessive Alport syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5432981" TraitType="Disease" MappingType="XRef" MappingValue="203780" MappingRef="OMIM">
        <MedGen CUI="C4746745" Name="Autosomal recessive Alport syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5432981" TraitType="Disease" MappingType="XRef" MappingValue="141200" MappingRef="OMIM">
        <MedGen CUI="CN376803" Name="Hematuria, benign familial, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5432981" TraitType="Disease" MappingType="XRef" MappingValue="104200" MappingRef="OMIM">
        <MedGen CUI="C5882663" Name="Autosomal dominant Alport syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

